— Know what they know.
Not Investment Advice
Also trades as: 0575.HK (HKSE) · $vol 0M

RPGLF OTC

Regent Pacific Group Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -95.3% 1Y: -94.1% 3Y: -98.5% 5Y: -97.6%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 40 · $1.7M mcap · 2M float · 0.0020% daily turnover · Short 81% of daily vol

Income Trends

Revenue
$349K -51.5% ▼
5Y CAGR: -26.9%
Gross Profit
$341K +255.5% ▲
Operating Income
-$4M +0.4% ▲
Net Income
-$5M -5.2% ▼
EPS (Diluted)
$-0.02 +8.2% ▲
EBITDA
-$4M -124.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$3M$114K$382K$719K$349K
YoY Growth+94.9%-96.5%+235.1%+88.2%-51.5%
Cost of Revenue$2M$3M$3M$938K$8K
Gross Profit$850K-$1M-$2M-$219K$341K
Gross Margin26.1%-971.1%-613.1%-30.5%97.7%
R&D Expenses$2M$1M$1M$938K$0
SG&A Expenses$927K$863K$703K$565K$0
Operating Expenses$15M$34M$28M$4M$5M
Operating Income-$14M-$35M-$30M-$4M-$4M
Operating Margin-426.3%-30697.4%-7953.7%-603.2%-1239.1%
Interest Expense$1M$1M$80K$171K$369K
Income Before Tax-$15M-$36M-$30M-$5M-$5M
Tax Expense-$2M$419K-$5M-$26K$0
Net Income-$13M-$36M-$25M-$4M-$5M
Net Margin-387.2%-31953.5%-6557.3%-623.4%-1353.5%
EPS (Diluted)$-0.10$-0.30$-0.11$-0.02$-0.02
EBITDA$10M-$10M-$8M$18M-$4M
Shares Outstanding120M120M225M228M34M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms